<HTML><HEAD><TITLE>Gene Ontology Results</TITLE></HEAD><BODY>
<H1>Gene Ontology Enrichment Results</H1>
<A HREF="homerResults.html">Homer <i>de novo</i> Motif Enrichment Results</A><BR/>
<A HREF="knownResults.html">Known Motif Enrichment Results</A><BR/>
<H4>Text file version of complete results (i.e. open with Excel)
<UL>
<LI><A HREF="biological_process.txt">biological process</A>: Functional groupings of proteins (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="molecular_function.txt">molecular function</A>: Mechanistic actions of proteins (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="cellular_component.txt">cellular component</A>: Protein localization (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="chromosome.txt">chromosome location</A>: Genes with similar chromosome localization (<A HREF="http://www.ncbi.nlm.nih.gov/gene">NCBI Gene</A>)</LI>
<LI><A HREF="kegg.txt">KEGG pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.genome.jp/kegg/pathway.html">KEGG</A>)</LI>
<LI><A HREF="interactions.txt">protein interactions</A>: "Proteins interacting with a common protein (BIND, EcoCyc, HPRD)" (<A HREF="http://www.ncbi.nlm.nih.gov/gene">NCBI Gene</A>)</LI>
<LI><A HREF="interpro.txt">interpro domains</A>: Proteins with similar domains and features (<A HREF="http://www.ebi.ac.uk/interpro/">Interpro</A>)</LI>
<LI><A HREF="pfam.txt">pfam domains</A>: Proteins with similar domains and features (<A HREF="http://www.sanger.ac.uk/Software/Pfam/">Pfam</A>)</LI>
<LI><A HREF="smart.txt">smart domains</A>: Proteins with similar domains and features (<A HREF="http://smart.embl-heidelberg.de/">SMART</A>)</LI>
<LI><A HREF="gene3d.txt">gene3d domains</A>: Proteins with similar domains and features (<A HREF="http://cathwww.biochem.ucl.ac.uk:8080/Gene3D">Gene3D</A>)</LI>
<LI><A HREF="prosite.txt">prosite domains</A>: Proteins with similar domains and features (<A HREF="http://ca.expasy.org/prosite/">Prosite</A>)</LI>
<LI><A HREF="prints.txt">prints domains</A>: Proteins with similar domains and features (<A HREF="http://www.bioinf.manchester.ac.uk/dbbrowser/PRINTS/">PRINTS</A>)</LI>
<LI><A HREF="msigdb.txt">MSigDB lists</A>: "Genes sets for pathways, factor/miRNA target predictions, expression patterns, etc." (<A HREF="http://www.broadinstitute.org/gsea/msigdb/index.jsp">MSigDB</A>)</LI>
<LI><A HREF="biocyc.txt">BIOCYC pathways</A>: Groups of proteins in the same pathways (<A HREF="http://biocyc.org/">BIOCYC</A>)</LI>
<LI><A HREF="cosmic.txt">COSMIC cancer mutations</A>: Genes mutated in similar cancers (<A HREF="http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/">COSMIC</A>)</LI>
<LI><A HREF="gwas.txt">GWAS genes</A>: Genes mutated in similar diseases (<A HREF="http://www.genome.gov/26525384">GWAS Catalog</A>)</LI>
<LI><A HREF="lipidmaps.txt">Lipid Maps pathways</A>: Groups of proteins in the same lipid pathways (<A HREF="http://www.ncbi.nlm.nih.gov/biosystems/">Lipid Maps/Biosystems</A>)</LI>
<LI><A HREF="pathwayInteractionDB.txt">Pathway Interaction DB</A>: Groups of proteins in the same pathways (<A HREF="http://pid.nci.nih.gov/">Pathway Interaction Database</A>)</LI>
<LI><A HREF="reactome.txt">REACTOME pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.reactome.org/PathwayBrowser/">REACTOME</A>)</LI>
<LI><A HREF="smpdb.txt">SMPDB pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.smpdb.ca/">SMPDB</A>)</LI>
<LI><A HREF="wikipathways.txt">WikiPathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.wikipathways.org/index.php/Special:BrowsePathwaysPage">Wikipathways</A>)</LI>
</UL>
<H2>Enriched Categories</H2>
<TABLE border="1" cellpading="0" cellspacing="0">
<TR><TH>P-value</TH><TD>ln(P)</TD><TD>Term</TD><TD>GO Tree</TD><TD>GO ID</TD><TD># of Genes in Term</TD><TD># of Target Genes in Term</TD><TD># of Total Genes</TD><TD># of Target Genes</TD><TD>Common Genes</TD></TR>
<TR><TD>5.266e-05</TD><TD>-9.85</TD><TD>HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP</TD><TD>MSigDB lists</TD><TD>HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP</TD><TD>75</TD><TD>2</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2,MECOM</TD></TR>
<TR><TD>1.247e-04</TD><TD>-8.99</TD><TD>NLRP14 (NLR family, pyrin domain containing 14)</TD><TD>protein interactions</TD><TD>338323</TD><TD>1</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.640e-04</TD><TD>-8.72</TD><TD>SUN3</TD><TD>interpro domains</TD><TD>IPR030274</TD><TD>1</TD><TD>1</TD><TD>18293</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>1.640e-04</TD><TD>-8.72</TD><TD>MDS1</TD><TD>interpro domains</TD><TD>IPR026710</TD><TD>1</TD><TD>1</TD><TD>18293</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.287e-04</TD><TD>-8.38</TD><TD>PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN</TD><TD>MSigDB lists</TD><TD>PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN</TD><TD>156</TD><TD>2</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2,MECOM</TD></TR>
<TR><TD>3.079e-04</TD><TD>-8.09</TD><TD>GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN</TD><TD>181</TD><TD>2</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2,MECOM</TD></TR>
<TR><TD>3.280e-04</TD><TD>-8.02</TD><TD>Evi1/Prdm16</TD><TD>interpro domains</TD><TD>IPR030413</TD><TD>2</TD><TD>1</TD><TD>18293</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.919e-04</TD><TD>-7.62</TD><TD>Procol_lys_dOase</TD><TD>interpro domains</TD><TD>IPR001006</TD><TD>3</TD><TD>1</TD><TD>18293</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>5.457e-04</TD><TD>-7.51</TD><TD>procollagen-lysine 5-dioxygenase activity</TD><TD>molecular function</TD><TD>GO:0008475</TD><TD>3</TD><TD>1</TD><TD>16491</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>6.235e-04</TD><TD>-7.38</TD><TD>Fam107b (family with sequence similarity 107, member B)</TD><TD>protein interactions</TD><TD>66540</TD><TD>5</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>7.215e-04</TD><TD>-7.23</TD><TD>2OG-FeII_Oxy</TD><TD>pfam domains</TD><TD>PF03171</TD><TD>4</TD><TD>1</TD><TD>16629</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>7.275e-04</TD><TD>-7.23</TD><TD>peptidyl-lysine 5-dioxygenase activity</TD><TD>molecular function</TD><TD>GO:0070815</TD><TD>4</TD><TD>1</TD><TD>16491</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>7.583e-04</TD><TD>-7.18</TD><TD>LYS_HYDROXYLASE</TD><TD>prosite domains</TD><TD>PS01325</TD><TD>3</TD><TD>1</TD><TD>11866</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.013e-03</TD><TD>-6.89</TD><TD>PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN</TD><TD>MSigDB lists</TD><TD>PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN</TD><TD>6</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.094e-03</TD><TD>-6.82</TD><TD>positive regulation of brown fat cell differentiation</TD><TD>biological process</TD><TD>GO:0090336</TD><TD>6</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.148e-03</TD><TD>-6.77</TD><TD>SUN_dom</TD><TD>interpro domains</TD><TD>IPR012919</TD><TD>7</TD><TD>1</TD><TD>18293</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>1.182e-03</TD><TD>-6.74</TD><TD>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7</TD><TD>MSigDB lists</TD><TD>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7</TD><TD>7</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.195e-03</TD><TD>-6.73</TD><TD>microtubule organizing center attachment site</TD><TD>cellular component</TD><TD>GO:0034992</TD><TD>7</TD><TD>1</TD><TD>17570</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>1.195e-03</TD><TD>-6.73</TD><TD>LINC complex</TD><TD>cellular component</TD><TD>GO:0034993</TD><TD>7</TD><TD>1</TD><TD>17570</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>1.256e-03</TD><TD>-6.68</TD><TD>Nasopharyngeal carcinoma(PMID:20512145)</TD><TD>GWAS genes</TD><TD>Nasopharyngeal carcinoma(PMID:20512145)</TD><TD>3</TD><TD>1</TD><TD>2389</TD><TD>1</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.262e-03</TD><TD>-6.67</TD><TD>Sad1_UNC</TD><TD>pfam domains</TD><TD>PF07738</TD><TD>7</TD><TD>1</TD><TD>16629</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>1.277e-03</TD><TD>-6.66</TD><TD>regulation of brown fat cell differentiation</TD><TD>biological process</TD><TD>GO:0090335</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.371e-03</TD><TD>-6.59</TD><TD>ITGB1BP2 (integrin beta 1 binding protein (melusin) 2)</TD><TD>protein interactions</TD><TD>26548</TD><TD>11</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.459e-03</TD><TD>-6.53</TD><TD>neutrophil homeostasis</TD><TD>biological process</TD><TD>GO:0001780</TD><TD>8</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.459e-03</TD><TD>-6.53</TD><TD>cytoskeletal anchoring at nuclear membrane</TD><TD>biological process</TD><TD>GO:0090286</TD><TD>8</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>1.496e-03</TD><TD>-6.50</TD><TD>SPDEF (SAM pointed domain containing ETS transcription factor)</TD><TD>protein interactions</TD><TD>25803</TD><TD>12</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.516e-03</TD><TD>-6.49</TD><TD>SUN</TD><TD>prosite domains</TD><TD>PS51469</TD><TD>6</TD><TD>1</TD><TD>11866</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>1.689e-03</TD><TD>-6.38</TD><TD>OXIDOREDUCTASE_ACTIVITY_GO_0016706</TD><TD>MSigDB lists</TD><TD>OXIDOREDUCTASE_ACTIVITY_GO_0016706</TD><TD>10</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.713e-03</TD><TD>-6.37</TD><TD>human chr7p12.3</TD><TD>chromosome location</TD><TD>human chr7p12.3</TD><TD>15</TD><TD>1</TD><TD>26250</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>1.745e-03</TD><TD>-6.35</TD><TD>COLGALT1 (collagen beta(1-O)galactosyltransferase 1)</TD><TD>protein interactions</TD><TD>79709</TD><TD>14</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.942e-03</TD><TD>-6.24</TD><TD>human chr3q26.2</TD><TD>chromosome location</TD><TD>human chr3q26.2</TD><TD>17</TD><TD>1</TD><TD>26250</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.093e-03</TD><TD>-6.17</TD><TD>Diastolic blood pressure(PMID:19430483)</TD><TD>GWAS genes</TD><TD>Diastolic blood pressure(PMID:19430483)</TD><TD>5</TD><TD>1</TD><TD>2389</TD><TD>1</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.170e-03</TD><TD>-6.13</TD><TD>human chr3q24</TD><TD>chromosome location</TD><TD>human chr3q24</TD><TD>19</TD><TD>1</TD><TD>26250</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.195e-03</TD><TD>-6.12</TD><TD>WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP</TD><TD>MSigDB lists</TD><TD>WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP</TD><TD>13</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.493e-03</TD><TD>-5.99</TD><TD>RNF123 (ring finger protein 123)</TD><TD>protein interactions</TD><TD>63891</TD><TD>20</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.512e-03</TD><TD>-5.99</TD><TD>Magnesium levels(PMID:20700443)</TD><TD>GWAS genes</TD><TD>Magnesium levels(PMID:20700443)</TD><TD>6</TD><TD>1</TD><TD>2389</TD><TD>1</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.553e-03</TD><TD>-5.97</TD><TD>hematopoietic stem cell proliferation</TD><TD>biological process</TD><TD>GO:0071425</TD><TD>14</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.617e-03</TD><TD>-5.95</TD><TD>TPP2 (tripeptidyl peptidase II)</TD><TD>protein interactions</TD><TD>7174</TD><TD>21</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.622e-03</TD><TD>-5.94</TD><TD>Pro_4_hyd_alph</TD><TD>interpro domains</TD><TD>IPR006620</TD><TD>16</TD><TD>1</TD><TD>18293</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.726e-03</TD><TD>-5.90</TD><TD>protein anchor</TD><TD>molecular function</TD><TD>GO:0043495</TD><TD>15</TD><TD>1</TD><TD>16491</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>2.742e-03</TD><TD>-5.90</TD><TD>MECOM (MDS1 and EVI1 complex locus)</TD><TD>protein interactions</TD><TD>2122</TD><TD>22</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.930e-03</TD><TD>-5.83</TD><TD>Systolic blood pressure(PMID:19430479)</TD><TD>GWAS genes</TD><TD>Systolic blood pressure(PMID:19430479)</TD><TD>7</TD><TD>1</TD><TD>2389</TD><TD>1</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.038e-03</TD><TD>-5.80</TD><TD>MODULE_478</TD><TD>MSigDB lists</TD><TD>MODULE_478</TD><TD>18</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.207e-03</TD><TD>-5.74</TD><TD>chr3q24</TD><TD>MSigDB lists</TD><TD>chr3q24</TD><TD>19</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.207e-03</TD><TD>-5.74</TD><TD>chr7p12</TD><TD>MSigDB lists</TD><TD>chr7p12</TD><TD>19</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>3.240e-03</TD><TD>-5.73</TD><TD>NUSAP1 (nucleolar and spindle associated protein 1)</TD><TD>protein interactions</TD><TD>51203</TD><TD>26</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.241e-03</TD><TD>-5.73</TD><TD>rough endoplasmic reticulum membrane</TD><TD>cellular component</TD><TD>GO:0030867</TD><TD>19</TD><TD>1</TD><TD>17570</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.281e-03</TD><TD>-5.72</TD><TD>pericardium development</TD><TD>biological process</TD><TD>GO:0060039</TD><TD>18</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.349e-03</TD><TD>-5.70</TD><TD>Immune reponse to smallpox (secreted IL-1beta)(PMID:22610502)</TD><TD>GWAS genes</TD><TD>Immune reponse to smallpox (secreted IL-1beta)(PMID:22610502)</TD><TD>8</TD><TD>1</TD><TD>2389</TD><TD>1</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.365e-03</TD><TD>-5.69</TD><TD>DNPEP (aspartyl aminopeptidase)</TD><TD>protein interactions</TD><TD>23549</TD><TD>27</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.440e-03</TD><TD>-5.67</TD><TD>Oxoglu/Fe-dep_dioxygenase</TD><TD>interpro domains</TD><TD>IPR005123</TD><TD>21</TD><TD>1</TD><TD>18293</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.502e-03</TD><TD>-5.65</TD><TD>P4Hc</TD><TD>smart domains</TD><TD>SM00702</TD><TD>16</TD><TD>1</TD><TD>9131</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.544e-03</TD><TD>-5.64</TD><TD>NUMATA_CSF3_SIGNALING_VIA_STAT3</TD><TD>MSigDB lists</TD><TD>NUMATA_CSF3_SIGNALING_VIA_STAT3</TD><TD>21</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.614e-03</TD><TD>-5.62</TD><TD>SWAP70 (SWAP switching B-cell complex 70kDa subunit)</TD><TD>protein interactions</TD><TD>23075</TD><TD>29</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.738e-03</TD><TD>-5.59</TD><TD>VASN (vasorin)</TD><TD>protein interactions</TD><TD>114990</TD><TD>30</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.816e-03</TD><TD>-5.57</TD><TD>L-ascorbic acid binding</TD><TD>molecular function</TD><TD>GO:0031418</TD><TD>21</TD><TD>1</TD><TD>16491</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.845e-03</TD><TD>-5.56</TD><TD>CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN</TD><TD>MSigDB lists</TD><TD>CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN</TD><TD>644</TD><TD>2</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2,MECOM</TD></TR>
<TR><TD>4.049e-03</TD><TD>-5.51</TD><TD>CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN</TD><TD>MSigDB lists</TD><TD>CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN</TD><TD>24</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.186e-03</TD><TD>-5.48</TD><TD>Renal function-related traits (BUN)(PMID:22797727)</TD><TD>GWAS genes</TD><TD>Renal function-related traits (BUN)(PMID:22797727)</TD><TD>10</TD><TD>1</TD><TD>2389</TD><TD>1</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.236e-03</TD><TD>-5.46</TD><TD>CSDE1 (cold shock domain containing E1, RNA binding)</TD><TD>protein interactions</TD><TD>7812</TD><TD>34</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.361e-03</TD><TD>-5.44</TD><TD>FARSB (phenylalanyl-tRNA synthetase beta subunit)</TD><TD>protein interactions</TD><TD>10056</TD><TD>35</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.386e-03</TD><TD>-5.43</TD><TD>VALK_AML_CLUSTER_1</TD><TD>MSigDB lists</TD><TD>VALK_AML_CLUSTER_1</TD><TD>26</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.485e-03</TD><TD>-5.41</TD><TD>PRMT3 (protein arginine methyltransferase 3)</TD><TD>protein interactions</TD><TD>10196</TD><TD>36</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.555e-03</TD><TD>-5.39</TD><TD>RESPONSE_TO_HYPOXIA</TD><TD>MSigDB lists</TD><TD>RESPONSE_TO_HYPOXIA</TD><TD>27</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.555e-03</TD><TD>-5.39</TD><TD>WOTTON_RUNX_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>WOTTON_RUNX_TARGETS_DN</TD><TD>27</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.604e-03</TD><TD>-5.38</TD><TD>Diastolic blood pressure(PMID:21909115)</TD><TD>GWAS genes</TD><TD>Diastolic blood pressure(PMID:21909115)</TD><TD>11</TD><TD>1</TD><TD>2389</TD><TD>1</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.779e-03</TD><TD>-5.34</TD><TD>NUYTTEN_NIPP1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>NUYTTEN_NIPP1_TARGETS_UP</TD><TD>719</TD><TD>2</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2,MECOM</TD></TR>
<TR><TD>5.023e-03</TD><TD>-5.29</TD><TD>Systolic blood pressure(PMID:21909115)</TD><TD>GWAS genes</TD><TD>Systolic blood pressure(PMID:21909115)</TD><TD>12</TD><TD>1</TD><TD>2389</TD><TD>1</TD>
<TD>MECOM</TD></TR>
<TR><TD>5.107e-03</TD><TD>-5.28</TD><TD>PLOD2 (procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2)</TD><TD>protein interactions</TD><TD>5352</TD><TD>41</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>5.228e-03</TD><TD>-5.25</TD><TD>TAVOR_CEBPA_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>TAVOR_CEBPA_TARGETS_DN</TD><TD>31</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>5.228e-03</TD><TD>-5.25</TD><TD>GNF2_MMP1</TD><TD>MSigDB lists</TD><TD>GNF2_MMP1</TD><TD>31</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>5.228e-03</TD><TD>-5.25</TD><TD>ROZANOV_MMP14_TARGETS_SUBSET</TD><TD>MSigDB lists</TD><TD>ROZANOV_MMP14_TARGETS_SUBSET</TD><TD>31</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>5.283e-03</TD><TD>-5.24</TD><TD>embryonic hindlimb morphogenesis</TD><TD>biological process</TD><TD>GO:0035116</TD><TD>29</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>5.300e-03</TD><TD>-5.24</TD><TD>FE2OG_OXY</TD><TD>prosite domains</TD><TD>PS51471</TD><TD>21</TD><TD>1</TD><TD>11866</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>5.356e-03</TD><TD>-5.23</TD><TD>RANBP3 (RAN binding protein 3)</TD><TD>protein interactions</TD><TD>8498</TD><TD>43</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>5.397e-03</TD><TD>-5.22</TD><TD>GRADE_COLON_CANCER_DN</TD><TD>MSigDB lists</TD><TD>GRADE_COLON_CANCER_DN</TD><TD>32</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>5.480e-03</TD><TD>-5.21</TD><TD>PACSIN2 (protein kinase C and casein kinase substrate in neurons 2)</TD><TD>protein interactions</TD><TD>11252</TD><TD>44</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>5.565e-03</TD><TD>-5.19</TD><TD>DOANE_BREAST_CANCER_CLASSES_DN</TD><TD>MSigDB lists</TD><TD>DOANE_BREAST_CANCER_CLASSES_DN</TD><TD>33</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>5.624e-03</TD><TD>-5.18</TD><TD>aggresome</TD><TD>cellular component</TD><TD>GO:0016235</TD><TD>33</TD><TD>1</TD><TD>17570</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>5.828e-03</TD><TD>-5.15</TD><TD>negative regulation of JNK cascade</TD><TD>biological process</TD><TD>GO:0046329</TD><TD>32</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>5.902e-03</TD><TD>-5.13</TD><TD>OXIDOREDUCTASE_ACTIVITY_GO_0016705</TD><TD>MSigDB lists</TD><TD>OXIDOREDUCTASE_ACTIVITY_GO_0016705</TD><TD>35</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>5.978e-03</TD><TD>-5.12</TD><TD>SAMHD1 (SAM domain and HD domain 1)</TD><TD>protein interactions</TD><TD>25939</TD><TD>48</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>6.070e-03</TD><TD>-5.10</TD><TD>QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2</TD><TD>MSigDB lists</TD><TD>QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2</TD><TD>36</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>6.070e-03</TD><TD>-5.10</TD><TD>GNF2_PTX3</TD><TD>MSigDB lists</TD><TD>GNF2_PTX3</TD><TD>36</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>6.192e-03</TD><TD>-5.08</TD><TD>embryonic forelimb morphogenesis</TD><TD>biological process</TD><TD>GO:0035115</TD><TD>34</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>6.226e-03</TD><TD>-5.08</TD><TD>NARS (asparaginyl-tRNA synthetase)</TD><TD>protein interactions</TD><TD>4677</TD><TD>50</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>6.238e-03</TD><TD>-5.08</TD><TD>HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN</TD><TD>MSigDB lists</TD><TD>HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN</TD><TD>37</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>6.298e-03</TD><TD>-5.07</TD><TD>DACOSTA_UV_RESPONSE_VIA_ERCC3_DN</TD><TD>MSigDB lists</TD><TD>DACOSTA_UV_RESPONSE_VIA_ERCC3_DN</TD><TD>827</TD><TD>2</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2,MECOM</TD></TR>
<TR><TD>6.351e-03</TD><TD>-5.06</TD><TD>UGP2 (UDP-glucose pyrophosphorylase 2)</TD><TD>protein interactions</TD><TD>7360</TD><TD>51</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>6.475e-03</TD><TD>-5.04</TD><TD>GART (phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase)</TD><TD>protein interactions</TD><TD>2618</TD><TD>52</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>6.475e-03</TD><TD>-5.04</TD><TD>PTPN12 (protein tyrosine phosphatase, non-receptor type 12)</TD><TD>protein interactions</TD><TD>5782</TD><TD>52</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>6.911e-03</TD><TD>-4.97</TD><TD>KEGG_LYSINE_DEGRADATION</TD><TD>MSigDB lists</TD><TD>KEGG_LYSINE_DEGRADATION</TD><TD>41</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>6.918e-03</TD><TD>-4.97</TD><TD>hindlimb morphogenesis</TD><TD>biological process</TD><TD>GO:0035137</TD><TD>38</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>7.079e-03</TD><TD>-4.95</TD><TD>JAEGER_METASTASIS_UP</TD><TD>MSigDB lists</TD><TD>JAEGER_METASTASIS_UP</TD><TD>42</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>7.100e-03</TD><TD>-4.95</TD><TD>negative regulation of stress-activated protein kinase signaling cascade</TD><TD>biological process</TD><TD>GO:0070303</TD><TD>39</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>7.100e-03</TD><TD>-4.95</TD><TD>negative regulation of stress-activated MAPK cascade</TD><TD>biological process</TD><TD>GO:0032873</TD><TD>39</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>7.122e-03</TD><TD>-4.94</TD><TD>organelle organization</TD><TD>biological process</TD><TD>GO:0006996</TD><TD>3164</TD><TD>3</TD><TD>16441</TD><TD>3</TD>
<TD>SUN3,PLOD2,MECOM</TD></TR>
<TR><TD>7.415e-03</TD><TD>-4.90</TD><TD>PARK_HSC_MARKERS</TD><TD>MSigDB lists</TD><TD>PARK_HSC_MARKERS</TD><TD>44</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>7.535e-03</TD><TD>-4.89</TD><TD>Pulmonary function(PMID:21946350)</TD><TD>GWAS genes</TD><TD>Pulmonary function(PMID:21946350)</TD><TD>18</TD><TD>1</TD><TD>2389</TD><TD>1</TD>
<TD>MECOM</TD></TR>
<TR><TD>7.594e-03</TD><TD>-4.88</TD><TD>OS9 (osteosarcoma amplified 9, endoplasmic reticulum lectin)</TD><TD>protein interactions</TD><TD>10956</TD><TD>61</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>7.645e-03</TD><TD>-4.87</TD><TD>forelimb morphogenesis</TD><TD>biological process</TD><TD>GO:0035136</TD><TD>42</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>8.080e-03</TD><TD>-4.82</TD><TD>haematopoietic_and_lymphoid_tissue-breast-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-breast-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma</TD><TD>48</TD><TD>1</TD><TD>17775</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>8.164e-03</TD><TD>-4.81</TD><TD>oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors</TD><TD>molecular function</TD><TD>GO:0016706</TD><TD>45</TD><TD>1</TD><TD>16491</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>8.256e-03</TD><TD>-4.80</TD><TD>FRASOR_TAMOXIFEN_RESPONSE_UP</TD><TD>MSigDB lists</TD><TD>FRASOR_TAMOXIFEN_RESPONSE_UP</TD><TD>49</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>8.256e-03</TD><TD>-4.80</TD><TD>MODULE_61</TD><TD>MSigDB lists</TD><TD>MODULE_61</TD><TD>49</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>8.256e-03</TD><TD>-4.80</TD><TD>SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION</TD><TD>MSigDB lists</TD><TD>SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION</TD><TD>49</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>8.256e-03</TD><TD>-4.80</TD><TD>SU_PANCREAS</TD><TD>MSigDB lists</TD><TD>SU_PANCREAS</TD><TD>49</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>8.341e-03</TD><TD>-4.79</TD><TD>SET_dom</TD><TD>interpro domains</TD><TD>IPR001214</TD><TD>51</TD><TD>1</TD><TD>18293</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>8.372e-03</TD><TD>-4.78</TD><TD>Blood pressure(PMID:21909110)</TD><TD>GWAS genes</TD><TD>Blood pressure(PMID:21909110)</TD><TD>20</TD><TD>1</TD><TD>2389</TD><TD>1</TD>
<TD>MECOM</TD></TR>
<TR><TD>8.463e-03</TD><TD>-4.77</TD><TD>GANAB (glucosidase, alpha; neutral AB)</TD><TD>protein interactions</TD><TD>23193</TD><TD>68</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>8.463e-03</TD><TD>-4.77</TD><TD>XPO7 (exportin 7)</TD><TD>protein interactions</TD><TD>23039</TD><TD>68</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>8.587e-03</TD><TD>-4.76</TD><TD>MBD3 (methyl-CpG binding domain protein 3)</TD><TD>protein interactions</TD><TD>53615</TD><TD>69</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>8.734e-03</TD><TD>-4.74</TD><TD>positive regulation of fat cell differentiation</TD><TD>biological process</TD><TD>GO:0045600</TD><TD>48</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>8.928e-03</TD><TD>-4.72</TD><TD>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP</TD><TD>MSigDB lists</TD><TD>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP</TD><TD>53</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>8.928e-03</TD><TD>-4.72</TD><TD>BOYLAN_MULTIPLE_MYELOMA_C_DN</TD><TD>MSigDB lists</TD><TD>BOYLAN_MULTIPLE_MYELOMA_C_DN</TD><TD>53</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>9.018e-03</TD><TD>-4.71</TD><TD>endomembrane system</TD><TD>cellular component</TD><TD>GO:0012505</TD><TD>3658</TD><TD>3</TD><TD>17570</TD><TD>3</TD>
<TD>SUN3,PLOD2,MECOM</TD></TR>
<TR><TD>9.095e-03</TD><TD>-4.70</TD><TD>MODULE_175</TD><TD>MSigDB lists</TD><TD>MODULE_175</TD><TD>54</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>9.095e-03</TD><TD>-4.70</TD><TD>REACTOME_COLLAGEN_FORMATION</TD><TD>MSigDB lists</TD><TD>REACTOME_COLLAGEN_FORMATION</TD><TD>54</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>9.431e-03</TD><TD>-4.66</TD><TD>MODULE_350</TD><TD>MSigDB lists</TD><TD>MODULE_350</TD><TD>56</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>9.581e-03</TD><TD>-4.65</TD><TD>SEC23A (Sec23 homolog A, COPII coat complex component)</TD><TD>protein interactions</TD><TD>10484</TD><TD>77</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>9.599e-03</TD><TD>-4.65</TD><TD>chr3q26</TD><TD>MSigDB lists</TD><TD>chr3q26</TD><TD>57</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>9.599e-03</TD><TD>-4.65</TD><TD>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN</TD><TD>MSigDB lists</TD><TD>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN</TD><TD>57</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>9.750e-03</TD><TD>-4.63</TD><TD>MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3</TD><TD>MSigDB lists</TD><TD>MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3</TD><TD>1033</TD><TD>2</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2,MECOM</TD></TR>
<TR><TD>1.004e-02</TD><TD>-4.60</TD><TD>histone deacetylase complex</TD><TD>cellular component</TD><TD>GO:0000118</TD><TD>59</TD><TD>1</TD><TD>17570</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.027e-02</TD><TD>-4.58</TD><TD>SET</TD><TD>smart domains</TD><TD>SM00317</TD><TD>47</TD><TD>1</TD><TD>9131</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.044e-02</TD><TD>-4.56</TD><TD>KYNG_DNA_DAMAGE_BY_UV</TD><TD>MSigDB lists</TD><TD>KYNG_DNA_DAMAGE_BY_UV</TD><TD>62</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.044e-02</TD><TD>-4.56</TD><TD>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN</TD><TD>MSigDB lists</TD><TD>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN</TD><TD>62</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.045e-02</TD><TD>-4.56</TD><TD>HSPH1 (heat shock 105kDa/110kDa protein 1)</TD><TD>protein interactions</TD><TD>10808</TD><TD>84</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.057e-02</TD><TD>-4.55</TD><TD>AP2B1 (adaptor-related protein complex 2, beta 1 subunit)</TD><TD>protein interactions</TD><TD>163</TD><TD>85</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.094e-02</TD><TD>-4.52</TD><TD>AAGTCCA,MIR-422B,MIR-422A</TD><TD>MSigDB lists</TD><TD>AAGTCCA,MIR-422B,MIR-422A</TD><TD>65</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.094e-02</TD><TD>-4.52</TD><TD>TENEDINI_MEGAKARYOCYTE_MARKERS</TD><TD>MSigDB lists</TD><TD>TENEDINI_MEGAKARYOCYTE_MARKERS</TD><TD>65</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.107e-02</TD><TD>-4.50</TD><TD>CTBP2 (C-terminal binding protein 2)</TD><TD>protein interactions</TD><TD>1488</TD><TD>89</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>stem cell proliferation</TD><TD>biological process</TD><TD>GO:0072089</TD><TD>61</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.123e-02</TD><TD>-4.49</TD><TD>rough endoplasmic reticulum</TD><TD>cellular component</TD><TD>GO:0005791</TD><TD>66</TD><TD>1</TD><TD>17570</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.128e-02</TD><TD>-4.49</TD><TD>GEORGANTAS_HSC_MARKERS</TD><TD>MSigDB lists</TD><TD>GEORGANTAS_HSC_MARKERS</TD><TD>67</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.144e-02</TD><TD>-4.47</TD><TD>ROSS_AML_OF_FAB_M7_TYPE</TD><TD>MSigDB lists</TD><TD>ROSS_AML_OF_FAB_M7_TYPE</TD><TD>68</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.163e-02</TD><TD>-4.45</TD><TD>leukocyte homeostasis</TD><TD>biological process</TD><TD>GO:0001776</TD><TD>64</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.169e-02</TD><TD>-4.45</TD><TD>PIAS4 (protein inhibitor of activated STAT 4)</TD><TD>protein interactions</TD><TD>51588</TD><TD>94</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.178e-02</TD><TD>-4.44</TD><TD>HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP</TD><TD>MSigDB lists</TD><TD>HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP</TD><TD>70</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.195e-02</TD><TD>-4.43</TD><TD>DER_IFN_GAMMA_RESPONSE_UP</TD><TD>MSigDB lists</TD><TD>DER_IFN_GAMMA_RESPONSE_UP</TD><TD>71</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.195e-02</TD><TD>-4.43</TD><TD>PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2</TD><TD>MSigDB lists</TD><TD>PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2</TD><TD>71</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.206e-02</TD><TD>-4.42</TD><TD>EHMT2 (euchromatic histone-lysine N-methyltransferase 2)</TD><TD>protein interactions</TD><TD>10919</TD><TD>97</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.207e-02</TD><TD>-4.42</TD><TD>inclusion body</TD><TD>cellular component</TD><TD>GO:0016234</TD><TD>71</TD><TD>1</TD><TD>17570</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.211e-02</TD><TD>-4.41</TD><TD>MODULE_120</TD><TD>MSigDB lists</TD><TD>MODULE_120</TD><TD>72</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.211e-02</TD><TD>-4.41</TD><TD>CROONQUIST_NRAS_SIGNALING_DN</TD><TD>MSigDB lists</TD><TD>CROONQUIST_NRAS_SIGNALING_DN</TD><TD>72</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.228e-02</TD><TD>-4.40</TD><TD>KEGG_CHRONIC_MYELOID_LEUKEMIA</TD><TD>MSigDB lists</TD><TD>KEGG_CHRONIC_MYELOID_LEUKEMIA</TD><TD>73</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.245e-02</TD><TD>-4.39</TD><TD>DER_IFN_ALPHA_RESPONSE_UP</TD><TD>MSigDB lists</TD><TD>DER_IFN_ALPHA_RESPONSE_UP</TD><TD>74</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.250e-02</TD><TD>-4.38</TD><TD>monosaccharide binding</TD><TD>molecular function</TD><TD>GO:0048029</TD><TD>69</TD><TD>1</TD><TD>16491</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.268e-02</TD><TD>-4.37</TD><TD>SET (SET nuclear proto-oncogene)</TD><TD>protein interactions</TD><TD>6418</TD><TD>102</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.279e-02</TD><TD>-4.36</TD><TD>LINDVALL_IMMORTALIZED_BY_TERT_DN</TD><TD>MSigDB lists</TD><TD>LINDVALL_IMMORTALIZED_BY_TERT_DN</TD><TD>76</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.279e-02</TD><TD>-4.36</TD><TD>MCBRYAN_PUBERTAL_BREAST_6_7WK_DN</TD><TD>MSigDB lists</TD><TD>MCBRYAN_PUBERTAL_BREAST_6_7WK_DN</TD><TD>76</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.284e-02</TD><TD>-4.36</TD><TD>SET</TD><TD>prosite domains</TD><TD>PS50280</TD><TD>51</TD><TD>1</TD><TD>11866</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.293e-02</TD><TD>-4.35</TD><TD>FAF1 (Fas (TNFRSF6) associated factor 1)</TD><TD>protein interactions</TD><TD>11124</TD><TD>104</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.295e-02</TD><TD>-4.35</TD><TD>LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP</TD><TD>MSigDB lists</TD><TD>LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP</TD><TD>77</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.326e-02</TD><TD>-4.32</TD><TD>nuclear envelope organization</TD><TD>biological process</TD><TD>GO:0006998</TD><TD>73</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>1.329e-02</TD><TD>-4.32</TD><TD>WALLACE_PROSTATE_CANCER_RACE_DN</TD><TD>MSigDB lists</TD><TD>WALLACE_PROSTATE_CANCER_RACE_DN</TD><TD>79</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.330e-02</TD><TD>-4.32</TD><TD>SUPT5H (SPT5 homolog, DSIF elongation factor subunit)</TD><TD>protein interactions</TD><TD>6829</TD><TD>107</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.344e-02</TD><TD>-4.31</TD><TD>negative regulation of transforming growth factor beta receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0030512</TD><TD>74</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.344e-02</TD><TD>-4.31</TD><TD>negative regulation of cellular response to transforming growth factor beta stimulus</TD><TD>biological process</TD><TD>GO:1903845</TD><TD>74</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.345e-02</TD><TD>-4.31</TD><TD>BASSO_HAIRY_CELL_LEUKEMIA_DN</TD><TD>MSigDB lists</TD><TD>BASSO_HAIRY_CELL_LEUKEMIA_DN</TD><TD>80</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.362e-02</TD><TD>-4.30</TD><TD>CTGYNNCTYTAA_UNKNOWN</TD><TD>MSigDB lists</TD><TD>CTGYNNCTYTAA_UNKNOWN</TD><TD>81</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.362e-02</TD><TD>-4.30</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP</TD><TD>MSigDB lists</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP</TD><TD>81</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.367e-02</TD><TD>-4.29</TD><TD>JUP (junction plakoglobin)</TD><TD>protein interactions</TD><TD>3728</TD><TD>110</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.396e-02</TD><TD>-4.27</TD><TD>REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION</TD><TD>MSigDB lists</TD><TD>REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION</TD><TD>83</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.396e-02</TD><TD>-4.27</TD><TD>HOEBEKE_LYMPHOID_STEM_CELL_DN</TD><TD>MSigDB lists</TD><TD>HOEBEKE_LYMPHOID_STEM_CELL_DN</TD><TD>83</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.429e-02</TD><TD>-4.25</TD><TD>LIU_VAV3_PROSTATE_CARCINOGENESIS_UP</TD><TD>MSigDB lists</TD><TD>LIU_VAV3_PROSTATE_CARCINOGENESIS_UP</TD><TD>85</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.429e-02</TD><TD>-4.25</TD><TD>SEIDEN_ONCOGENESIS_BY_MET</TD><TD>MSigDB lists</TD><TD>SEIDEN_ONCOGENESIS_BY_MET</TD><TD>85</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.429e-02</TD><TD>-4.25</TD><TD>KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP</TD><TD>MSigDB lists</TD><TD>KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP</TD><TD>85</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.430e-02</TD><TD>-4.25</TD><TD>vitamin binding</TD><TD>molecular function</TD><TD>GO:0019842</TD><TD>79</TD><TD>1</TD><TD>16491</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.453e-02</TD><TD>-4.23</TD><TD>Nucleotide-diphossugar_trans</TD><TD>interpro domains</TD><TD>IPR029044</TD><TD>89</TD><TD>1</TD><TD>18293</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.463e-02</TD><TD>-4.22</TD><TD>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C</TD><TD>MSigDB lists</TD><TD>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C</TD><TD>87</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.479e-02</TD><TD>-4.21</TD><TD>SF1 (splicing factor 1)</TD><TD>protein interactions</TD><TD>7536</TD><TD>119</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.489e-02</TD><TD>-4.21</TD><TD>maintenance of protein location in cell</TD><TD>biological process</TD><TD>GO:0032507</TD><TD>82</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>1.500e-02</TD><TD>-4.20</TD><TD>Lysine degradation</TD><TD>KEGG pathways</TD><TD>hsa00310</TD><TD>52</TD><TD>1</TD><TD>6908</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.500e-02</TD><TD>-4.20</TD><TD>Lysine degradation</TD><TD>KEGG pathways</TD><TD>ko00310</TD><TD>52</TD><TD>1</TD><TD>6908</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.530e-02</TD><TD>-4.18</TD><TD>CAATGCA,MIR-33</TD><TD>MSigDB lists</TD><TD>CAATGCA,MIR-33</TD><TD>91</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.555e-02</TD><TD>-4.16</TD><TD>PKMTs methylate histone lysines</TD><TD>REACTOME pathways</TD><TD>R-HSA-3214841</TD><TD>64</TD><TD>1</TD><TD>8202</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.555e-02</TD><TD>-4.16</TD><TD>Collagen biosynthesis and modifying enzymes</TD><TD>REACTOME pathways</TD><TD>R-HSA-1650814</TD><TD>64</TD><TD>1</TD><TD>8202</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.563e-02</TD><TD>-4.16</TD><TD>MENSE_HYPOXIA_UP</TD><TD>MSigDB lists</TD><TD>MENSE_HYPOXIA_UP</TD><TD>93</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.592e-02</TD><TD>-4.14</TD><TD>dioxygenase activity</TD><TD>molecular function</TD><TD>GO:0051213</TD><TD>88</TD><TD>1</TD><TD>16491</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.615e-02</TD><TD>-4.13</TD><TD>maintenance of protein location</TD><TD>biological process</TD><TD>GO:0045185</TD><TD>89</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>1.615e-02</TD><TD>-4.13</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.90.550.10</TD><TD>81</TD><TD>1</TD><TD>9988</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.627e-02</TD><TD>-4.12</TD><TD>USP15 (ubiquitin specific peptidase 15)</TD><TD>protein interactions</TD><TD>9958</TD><TD>131</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.630e-02</TD><TD>-4.12</TD><TD>skin-arm-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-arm-malignant_melanoma</TD><TD>1345</TD><TD>2</TD><TD>17775</TD><TD>3</TD>
<TD>PLOD2,MECOM</TD></TR>
<TR><TD>1.685e-02</TD><TD>-4.08</TD><TD>arm</TD><TD>COSMIC cancer mutations</TD><TD>arm</TD><TD>1368</TD><TD>2</TD><TD>17775</TD><TD>3</TD>
<TD>PLOD2,MECOM</TD></TR>
<TR><TD>1.687e-02</TD><TD>-4.08</TD><TD>maintenance of location in cell</TD><TD>biological process</TD><TD>GO:0051651</TD><TD>93</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>1.706e-02</TD><TD>-4.07</TD><TD>myeloid cell homeostasis</TD><TD>biological process</TD><TD>GO:0002262</TD><TD>94</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.713e-02</TD><TD>-4.07</TD><TD>DER_IFN_BETA_RESPONSE_UP</TD><TD>MSigDB lists</TD><TD>DER_IFN_BETA_RESPONSE_UP</TD><TD>102</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.713e-02</TD><TD>-4.07</TD><TD>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP</TD><TD>MSigDB lists</TD><TD>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP</TD><TD>102</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.714e-02</TD><TD>-4.07</TD><TD>PRMT1 (protein arginine methyltransferase 1)</TD><TD>protein interactions</TD><TD>3276</TD><TD>138</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.726e-02</TD><TD>-4.06</TD><TD>HDAC4 (histone deacetylase 4)</TD><TD>protein interactions</TD><TD>9759</TD><TD>139</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.730e-02</TD><TD>-4.06</TD><TD>SUNG_METASTASIS_STROMA_UP</TD><TD>MSigDB lists</TD><TD>SUNG_METASTASIS_STROMA_UP</TD><TD>103</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.730e-02</TD><TD>-4.06</TD><TD>IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN</TD><TD>MSigDB lists</TD><TD>IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN</TD><TD>103</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.788e-02</TD><TD>-4.02</TD><TD>RPL24 (ribosomal protein L24)</TD><TD>protein interactions</TD><TD>6152</TD><TD>144</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>1.814e-02</TD><TD>-4.01</TD><TD>post-embryonic development</TD><TD>biological process</TD><TD>GO:0009791</TD><TD>100</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.837e-02</TD><TD>-4.00</TD><TD>SUV39H1 (suppressor of variegation 3-9 homolog 1 (Drosophila))</TD><TD>protein interactions</TD><TD>6839</TD><TD>148</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.850e-02</TD><TD>-3.99</TD><TD>regulation of fat cell differentiation</TD><TD>biological process</TD><TD>GO:0045598</TD><TD>102</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.874e-02</TD><TD>-3.98</TD><TD>CTBP1 (C-terminal binding protein 1)</TD><TD>protein interactions</TD><TD>1487</TD><TD>151</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.879e-02</TD><TD>-3.97</TD><TD>myelodysplastic-myeloproliferative_neoplasm-unclassifiable</TD><TD>COSMIC cancer mutations</TD><TD>myelodysplastic-myeloproliferative_neoplasm-unclassifiable</TD><TD>112</TD><TD>1</TD><TD>17775</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.879e-02</TD><TD>-3.97</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic-myeloproliferative_neoplasm-unclassifiable</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic-myeloproliferative_neoplasm-unclassifiable</TD><TD>112</TD><TD>1</TD><TD>17775</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.897e-02</TD><TD>-3.96</TD><TD>WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP</TD><TD>MSigDB lists</TD><TD>WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP</TD><TD>113</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.922e-02</TD><TD>-3.95</TD><TD>regulation of cellular response to transforming growth factor beta stimulus</TD><TD>biological process</TD><TD>GO:1903844</TD><TD>106</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.922e-02</TD><TD>-3.95</TD><TD>regulation of transforming growth factor beta receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0017015</TD><TD>106</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.964e-02</TD><TD>-3.93</TD><TD>MISSIAGLIA_REGULATED_BY_METHYLATION_DN</TD><TD>MSigDB lists</TD><TD>MISSIAGLIA_REGULATED_BY_METHYLATION_DN</TD><TD>117</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>1.997e-02</TD><TD>-3.91</TD><TD>IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP</TD><TD>MSigDB lists</TD><TD>IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP</TD><TD>119</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.012e-02</TD><TD>-3.91</TD><TD>secretory</TD><TD>COSMIC cancer mutations</TD><TD>secretory</TD><TD>120</TD><TD>1</TD><TD>17775</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.012e-02</TD><TD>-3.91</TD><TD>meninges-meningioma-secretory</TD><TD>COSMIC cancer mutations</TD><TD>meninges-meningioma-secretory</TD><TD>120</TD><TD>1</TD><TD>17775</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.012e-02</TD><TD>-3.91</TD><TD>negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway</TD><TD>biological process</TD><TD>GO:0090101</TD><TD>111</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.014e-02</TD><TD>-3.91</TD><TD>TOOKER_GEMCITABINE_RESISTANCE_DN</TD><TD>MSigDB lists</TD><TD>TOOKER_GEMCITABINE_RESISTANCE_DN</TD><TD>120</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.060e-02</TD><TD>-3.88</TD><TD>SMAD1 (SMAD family member 1)</TD><TD>protein interactions</TD><TD>4086</TD><TD>166</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.086e-02</TD><TD>-3.87</TD><TD>Collagen formation</TD><TD>REACTOME pathways</TD><TD>R-HSA-1474290</TD><TD>86</TD><TD>1</TD><TD>8202</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.102e-02</TD><TD>-3.86</TD><TD>Chronic myeloid leukemia</TD><TD>KEGG pathways</TD><TD>ko05220</TD><TD>73</TD><TD>1</TD><TD>6908</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.102e-02</TD><TD>-3.86</TD><TD>Chronic myeloid leukemia</TD><TD>KEGG pathways</TD><TD>hsa05220</TD><TD>73</TD><TD>1</TD><TD>6908</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.164e-02</TD><TD>-3.83</TD><TD>RELA_DN.V1_DN</TD><TD>MSigDB lists</TD><TD>RELA_DN.V1_DN</TD><TD>129</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.197e-02</TD><TD>-3.82</TD><TD>CRX_DN.V1_DN</TD><TD>MSigDB lists</TD><TD>CRX_DN.V1_DN</TD><TD>131</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.257e-02</TD><TD>-3.79</TD><TD>KAT2B (K(lysine) acetyltransferase 2B)</TD><TD>protein interactions</TD><TD>8850</TD><TD>182</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.263e-02</TD><TD>-3.79</TD><TD>WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP</TD><TD>MSigDB lists</TD><TD>WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP</TD><TD>135</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.280e-02</TD><TD>-3.78</TD><TD>QI_HYPOXIA</TD><TD>MSigDB lists</TD><TD>QI_HYPOXIA</TD><TD>136</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.300e-02</TD><TD>-3.77</TD><TD>embryonic limb morphogenesis</TD><TD>biological process</TD><TD>GO:0030326</TD><TD>127</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.300e-02</TD><TD>-3.77</TD><TD>embryonic appendage morphogenesis</TD><TD>biological process</TD><TD>GO:0035113</TD><TD>127</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.313e-02</TD><TD>-3.77</TD><TD>CCAWYNNGAAR_UNKNOWN</TD><TD>MSigDB lists</TD><TD>CCAWYNNGAAR_UNKNOWN</TD><TD>138</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.318e-02</TD><TD>-3.76</TD><TD>nucleus organization</TD><TD>biological process</TD><TD>GO:0006997</TD><TD>128</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>2.363e-02</TD><TD>-3.75</TD><TD>PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN</TD><TD>MSigDB lists</TD><TD>PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN</TD><TD>141</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.389e-02</TD><TD>-3.73</TD><TD>negative regulation of cellular response to growth factor stimulus</TD><TD>biological process</TD><TD>GO:0090288</TD><TD>132</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.397e-02</TD><TD>-3.73</TD><TD>GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB</TD><TD>MSigDB lists</TD><TD>GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB</TD><TD>143</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.425e-02</TD><TD>-3.72</TD><TD>mitophagy in response to mitochondrial depolarization</TD><TD>biological process</TD><TD>GO:0098779</TD><TD>134</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.425e-02</TD><TD>-3.72</TD><TD>response to mitochondrial depolarisation</TD><TD>biological process</TD><TD>GO:0098780</TD><TD>134</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.446e-02</TD><TD>-3.71</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP</TD><TD>MSigDB lists</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP</TD><TD>146</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.461e-02</TD><TD>-3.70</TD><TD>maintenance of location</TD><TD>biological process</TD><TD>GO:0051235</TD><TD>136</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>2.480e-02</TD><TD>-3.70</TD><TD>TTCNRGNNNNTTC_V$HSF_Q6</TD><TD>MSigDB lists</TD><TD>TTCNRGNNNNTTC_V$HSF_Q6</TD><TD>148</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.496e-02</TD><TD>-3.69</TD><TD>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN</TD><TD>149</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>2.513e-02</TD><TD>-3.68</TD><TD>GSE6269_FLU_VS_E_COLI_INF_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE6269_FLU_VS_E_COLI_INF_PBMC_DN</TD><TD>150</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.527e-02</TD><TD>-3.68</TD><TD>chronic_myelomonocytic_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>chronic_myelomonocytic_leukaemia</TD><TD>151</TD><TD>1</TD><TD>17775</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.527e-02</TD><TD>-3.68</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-chronic_myelomonocytic_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-chronic_myelomonocytic_leukaemia</TD><TD>151</TD><TD>1</TD><TD>17775</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.529e-02</TD><TD>-3.68</TD><TD>TMTCGCGANR_UNKNOWN</TD><TD>MSigDB lists</TD><TD>TMTCGCGANR_UNKNOWN</TD><TD>151</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.533e-02</TD><TD>-3.68</TD><TD>negative regulation of MAPK cascade</TD><TD>biological process</TD><TD>GO:0043409</TD><TD>140</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.563e-02</TD><TD>-3.66</TD><TD>WINNEPENNINCKX_MELANOMA_METASTASIS_UP</TD><TD>MSigDB lists</TD><TD>WINNEPENNINCKX_MELANOMA_METASTASIS_UP</TD><TD>153</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.579e-02</TD><TD>-3.66</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN</TD><TD>154</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.590e-02</TD><TD>-3.65</TD><TD>SIRT1 (sirtuin 1)</TD><TD>protein interactions</TD><TD>23411</TD><TD>209</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.596e-02</TD><TD>-3.65</TD><TD>GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN</TD><TD>155</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>2.623e-02</TD><TD>-3.64</TD><TD>stem cell population maintenance</TD><TD>biological process</TD><TD>GO:0019827</TD><TD>145</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.629e-02</TD><TD>-3.64</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN</TD><TD>157</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>SUN3</TD></TR>
<TR><TD>2.641e-02</TD><TD>-3.63</TD><TD>maintenance of cell number</TD><TD>biological process</TD><TD>GO:0098727</TD><TD>146</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.664e-02</TD><TD>-3.63</TD><TD>RUVBL2 (RuvB-like AAA ATPase 2)</TD><TD>protein interactions</TD><TD>10856</TD><TD>215</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.676e-02</TD><TD>-3.62</TD><TD>SMAD4 (SMAD family member 4)</TD><TD>protein interactions</TD><TD>4089</TD><TD>216</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.694e-02</TD><TD>-3.61</TD><TD>appendage morphogenesis</TD><TD>biological process</TD><TD>GO:0035107</TD><TD>149</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.694e-02</TD><TD>-3.61</TD><TD>limb morphogenesis</TD><TD>biological process</TD><TD>GO:0035108</TD><TD>149</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.695e-02</TD><TD>-3.61</TD><TD>CAIRO_LIVER_DEVELOPMENT_UP</TD><TD>MSigDB lists</TD><TD>CAIRO_LIVER_DEVELOPMENT_UP</TD><TD>161</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.713e-02</TD><TD>-3.61</TD><TD>NCL (nucleolin)</TD><TD>protein interactions</TD><TD>4691</TD><TD>219</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.729e-02</TD><TD>-3.60</TD><TD>GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN</TD><TD>163</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.748e-02</TD><TD>-3.59</TD><TD>macromitophagy</TD><TD>biological process</TD><TD>GO:0000423</TD><TD>152</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.762e-02</TD><TD>-3.59</TD><TD>VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP</TD><TD>MSigDB lists</TD><TD>VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP</TD><TD>165</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.762e-02</TD><TD>-3.59</TD><TD>GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_UP</TD><TD>165</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.762e-02</TD><TD>-3.59</TD><TD>KATSANOU_ELAVL1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>KATSANOU_ELAVL1_TARGETS_UP</TD><TD>165</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.778e-02</TD><TD>-3.58</TD><TD>MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP</TD><TD>166</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.812e-02</TD><TD>-3.57</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP</TD><TD>MSigDB lists</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP</TD><TD>168</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.812e-02</TD><TD>-3.57</TD><TD>CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP</TD><TD>MSigDB lists</TD><TD>CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP</TD><TD>168</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.812e-02</TD><TD>-3.57</TD><TD>GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP</TD><TD>MSigDB lists</TD><TD>GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP</TD><TD>168</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.815e-02</TD><TD>-3.57</TD><TD>TGGAAA_V$NFAT_Q4_01</TD><TD>MSigDB lists</TD><TD>TGGAAA_V$NFAT_Q4_01</TD><TD>1781</TD><TD>2</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2,MECOM</TD></TR>
<TR><TD>2.828e-02</TD><TD>-3.57</TD><TD>GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP</TD><TD>169</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.845e-02</TD><TD>-3.56</TD><TD>YAMAZAKI_TCEB3_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>YAMAZAKI_TCEB3_TARGETS_UP</TD><TD>170</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.847e-02</TD><TD>-3.56</TD><TD>oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen</TD><TD>molecular function</TD><TD>GO:0016705</TD><TD>158</TD><TD>1</TD><TD>16491</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.856e-02</TD><TD>-3.56</TD><TD>regulation of JNK cascade</TD><TD>biological process</TD><TD>GO:0046328</TD><TD>158</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.861e-02</TD><TD>-3.55</TD><TD>PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP</TD><TD>MSigDB lists</TD><TD>PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP</TD><TD>171</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.878e-02</TD><TD>-3.55</TD><TD>CTACTGT,MIR-199A</TD><TD>MSigDB lists</TD><TD>CTACTGT,MIR-199A</TD><TD>172</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.894e-02</TD><TD>-3.54</TD><TD>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN</TD><TD>173</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.928e-02</TD><TD>-3.53</TD><TD>GSE2706_2H_VS_8H_R848_STIM_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_2H_VS_8H_R848_STIM_DC_DN</TD><TD>175</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.928e-02</TD><TD>-3.53</TD><TD>MODULE_126</TD><TD>MSigDB lists</TD><TD>MODULE_126</TD><TD>175</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.936e-02</TD><TD>-3.53</TD><TD>iron ion binding</TD><TD>molecular function</TD><TD>GO:0005506</TD><TD>163</TD><TD>1</TD><TD>16491</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.958e-02</TD><TD>-3.52</TD><TD>acute_myeloid_leukaemia_associated_with_MDS</TD><TD>COSMIC cancer mutations</TD><TD>acute_myeloid_leukaemia_associated_with_MDS</TD><TD>177</TD><TD>1</TD><TD>17775</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.958e-02</TD><TD>-3.52</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_associated_with_MDS</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_associated_with_MDS</TD><TD>177</TD><TD>1</TD><TD>17775</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>2.961e-02</TD><TD>-3.52</TD><TD>GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP</TD><TD>177</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.977e-02</TD><TD>-3.51</TD><TD>GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_UP</TD><TD>178</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>2.994e-02</TD><TD>-3.51</TD><TD>GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_DN</TD><TD>179</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.010e-02</TD><TD>-3.50</TD><TD>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP</TD><TD>MSigDB lists</TD><TD>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP</TD><TD>180</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.027e-02</TD><TD>-3.50</TD><TD>GSE22886_NEUTROPHIL_VS_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE22886_NEUTROPHIL_VS_MONOCYTE_UP</TD><TD>181</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.043e-02</TD><TD>-3.49</TD><TD>GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN</TD><TD>MSigDB lists</TD><TD>GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN</TD><TD>182</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.060e-02</TD><TD>-3.49</TD><TD>GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_DN</TD><TD>MSigDB lists</TD><TD>GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_DN</TD><TD>183</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.060e-02</TD><TD>-3.49</TD><TD>GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP</TD><TD>MSigDB lists</TD><TD>GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP</TD><TD>183</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.060e-02</TD><TD>-3.49</TD><TD>LEF1_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>LEF1_UP.V1_DN</TD><TD>183</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.077e-02</TD><TD>-3.48</TD><TD>BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP</TD><TD>MSigDB lists</TD><TD>BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP</TD><TD>184</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.077e-02</TD><TD>-3.48</TD><TD>ESC_V6.5_UP_LATE.V1_UP</TD><TD>MSigDB lists</TD><TD>ESC_V6.5_UP_LATE.V1_UP</TD><TD>184</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.081e-02</TD><TD>-3.48</TD><TD>TERF2 (telomeric repeat binding factor 2)</TD><TD>protein interactions</TD><TD>7014</TD><TD>249</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.088e-02</TD><TD>-3.48</TD><TD>limb development</TD><TD>biological process</TD><TD>GO:0060173</TD><TD>171</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.088e-02</TD><TD>-3.48</TD><TD>appendage development</TD><TD>biological process</TD><TD>GO:0048736</TD><TD>171</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.093e-02</TD><TD>-3.48</TD><TD>YAGI_AML_FAB_MARKERS</TD><TD>MSigDB lists</TD><TD>YAGI_AML_FAB_MARKERS</TD><TD>185</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.110e-02</TD><TD>-3.47</TD><TD>GSE30083_SP3_VS_SP4_THYMOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE30083_SP3_VS_SP4_THYMOCYTE_UP</TD><TD>186</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.126e-02</TD><TD>-3.47</TD><TD>GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP</TD><TD>MSigDB lists</TD><TD>GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP</TD><TD>187</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.126e-02</TD><TD>-3.47</TD><TD>GGGACCA,MIR-133A,MIR-133B</TD><TD>MSigDB lists</TD><TD>GGGACCA,MIR-133A,MIR-133B</TD><TD>187</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.143e-02</TD><TD>-3.46</TD><TD>XRCC6 (X-ray repair complementing defective repair in Chinese hamster cells 6)</TD><TD>protein interactions</TD><TD>2547</TD><TD>254</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.159e-02</TD><TD>-3.45</TD><TD>GSE30083_SP1_VS_SP4_THYMOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE30083_SP1_VS_SP4_THYMOCYTE_UP</TD><TD>189</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.159e-02</TD><TD>-3.45</TD><TD>GSE17721_4H_VS_24H_POLYIC_BMDM_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_4H_VS_24H_POLYIC_BMDM_UP</TD><TD>189</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.176e-02</TD><TD>-3.45</TD><TD>GSE17721_LPS_VS_PAM3CSK4_4H_BMDM_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_PAM3CSK4_4H_BMDM_UP</TD><TD>190</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.192e-02</TD><TD>-3.44</TD><TD>GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN</TD><TD>191</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.193e-02</TD><TD>-3.44</TD><TD>nuclear speck</TD><TD>cellular component</TD><TD>GO:0016607</TD><TD>189</TD><TD>1</TD><TD>17570</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.209e-02</TD><TD>-3.44</TD><TD>GSE3982_EOSINOPHIL_VS_TH1_DN</TD><TD>MSigDB lists</TD><TD>GSE3982_EOSINOPHIL_VS_TH1_DN</TD><TD>192</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.225e-02</TD><TD>-3.43</TD><TD>GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN</TD><TD>193</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.225e-02</TD><TD>-3.43</TD><TD>GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_DN</TD><TD>193</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.242e-02</TD><TD>-3.43</TD><TD>GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN</TD><TD>194</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.242e-02</TD><TD>-3.43</TD><TD>CTTGTAT,MIR-381</TD><TD>MSigDB lists</TD><TD>CTTGTAT,MIR-381</TD><TD>194</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.242e-02</TD><TD>-3.43</TD><TD>GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN</TD><TD>194</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.242e-02</TD><TD>-3.43</TD><TD>GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP</TD><TD>MSigDB lists</TD><TD>GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP</TD><TD>194</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.242e-02</TD><TD>-3.43</TD><TD>GSE7764_NKCELL_VS_SPLENOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE7764_NKCELL_VS_SPLENOCYTE_UP</TD><TD>194</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.242e-02</TD><TD>-3.43</TD><TD>GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_UP</TD><TD>MSigDB lists</TD><TD>GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_UP</TD><TD>194</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.258e-02</TD><TD>-3.42</TD><TD>GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP</TD><TD>MSigDB lists</TD><TD>GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP</TD><TD>195</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.258e-02</TD><TD>-3.42</TD><TD>GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDM_DN</TD><TD>195</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.258e-02</TD><TD>-3.42</TD><TD>HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION</TD><TD>MSigDB lists</TD><TD>HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION</TD><TD>195</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.258e-02</TD><TD>-3.42</TD><TD>GSE7852_LN_VS_FAT_TCONV_DN</TD><TD>MSigDB lists</TD><TD>GSE7852_LN_VS_FAT_TCONV_DN</TD><TD>195</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.267e-02</TD><TD>-3.42</TD><TD>mitophagy</TD><TD>biological process</TD><TD>GO:0000422</TD><TD>181</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.267e-02</TD><TD>-3.42</TD><TD>mitochondrion disassembly</TD><TD>biological process</TD><TD>GO:0061726</TD><TD>181</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.272e-02</TD><TD>-3.42</TD><TD>bone-femur-other-chondroblastoma</TD><TD>COSMIC cancer mutations</TD><TD>bone-femur-other-chondroblastoma</TD><TD>196</TD><TD>1</TD><TD>17775</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.275e-02</TD><TD>-3.42</TD><TD>SANSOM_APC_TARGETS</TD><TD>MSigDB lists</TD><TD>SANSOM_APC_TARGETS</TD><TD>196</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.291e-02</TD><TD>-3.41</TD><TD>HALLMARK_GLYCOLYSIS</TD><TD>MSigDB lists</TD><TD>HALLMARK_GLYCOLYSIS</TD><TD>197</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.308e-02</TD><TD>-3.41</TD><TD>HALLMARK_MTORC1_SIGNALING</TD><TD>MSigDB lists</TD><TD>HALLMARK_MTORC1_SIGNALING</TD><TD>198</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.308e-02</TD><TD>-3.41</TD><TD>GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN</TD><TD>MSigDB lists</TD><TD>GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN</TD><TD>198</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.338e-02</TD><TD>-3.40</TD><TD>homeostasis of number of cells</TD><TD>biological process</TD><TD>GO:0048872</TD><TD>185</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.341e-02</TD><TD>-3.40</TD><TD>V$STAT5A_04</TD><TD>MSigDB lists</TD><TD>V$STAT5A_04</TD><TD>200</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.358e-02</TD><TD>-3.39</TD><TD>RIZKI_TUMOR_INVASIVENESS_3D_UP</TD><TD>MSigDB lists</TD><TD>RIZKI_TUMOR_INVASIVENESS_3D_UP</TD><TD>201</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.358e-02</TD><TD>-3.39</TD><TD>MANALO_HYPOXIA_UP</TD><TD>MSigDB lists</TD><TD>MANALO_HYPOXIA_UP</TD><TD>201</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.374e-02</TD><TD>-3.39</TD><TD>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN</TD><TD>MSigDB lists</TD><TD>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN</TD><TD>202</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.388e-02</TD><TD>-3.38</TD><TD>UBL4A (ubiquitin-like 4A)</TD><TD>protein interactions</TD><TD>8266</TD><TD>274</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.391e-02</TD><TD>-3.38</TD><TD>KIM_WT1_TARGETS_12HR_DN</TD><TD>MSigDB lists</TD><TD>KIM_WT1_TARGETS_12HR_DN</TD><TD>203</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.391e-02</TD><TD>-3.38</TD><TD>CHANG_CORE_SERUM_RESPONSE_UP</TD><TD>MSigDB lists</TD><TD>CHANG_CORE_SERUM_RESPONSE_UP</TD><TD>203</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.417e-02</TD><TD>-3.38</TD><TD>cellular component organization</TD><TD>biological process</TD><TD>GO:0016043</TD><TD>5336</TD><TD>3</TD><TD>16441</TD><TD>3</TD>
<TD>SUN3,PLOD2,MECOM</TD></TR>
<TR><TD>3.445e-02</TD><TD>-3.37</TD><TD>regulation of stress-activated MAPK cascade</TD><TD>biological process</TD><TD>GO:0032872</TD><TD>191</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.457e-02</TD><TD>-3.36</TD><TD>BIDUS_METASTASIS_UP</TD><TD>MSigDB lists</TD><TD>BIDUS_METASTASIS_UP</TD><TD>207</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.463e-02</TD><TD>-3.36</TD><TD>regulation of stress-activated protein kinase signaling cascade</TD><TD>biological process</TD><TD>GO:0070302</TD><TD>192</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.474e-02</TD><TD>-3.36</TD><TD>SMAD2 (SMAD family member 2)</TD><TD>protein interactions</TD><TD>4087</TD><TD>281</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.490e-02</TD><TD>-3.36</TD><TD>AFFAR_YY1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>AFFAR_YY1_TARGETS_UP</TD><TD>209</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.490e-02</TD><TD>-3.36</TD><TD>V$VDR_Q3</TD><TD>MSigDB lists</TD><TD>V$VDR_Q3</TD><TD>209</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.506e-02</TD><TD>-3.35</TD><TD>BOQUEST_STEM_CELL_DN</TD><TD>MSigDB lists</TD><TD>BOQUEST_STEM_CELL_DN</TD><TD>210</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.523e-02</TD><TD>-3.35</TD><TD>MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP</TD><TD>MSigDB lists</TD><TD>MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP</TD><TD>211</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.523e-02</TD><TD>-3.35</TD><TD>VHL (von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase)</TD><TD>protein interactions</TD><TD>7428</TD><TD>285</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.524e-02</TD><TD>-3.35</TD><TD>carboxylic acid binding</TD><TD>molecular function</TD><TD>GO:0031406</TD><TD>196</TD><TD>1</TD><TD>16491</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.541e-02</TD><TD>-3.34</TD><TD>organic acid binding</TD><TD>molecular function</TD><TD>GO:0043177</TD><TD>197</TD><TD>1</TD><TD>16491</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.588e-02</TD><TD>-3.33</TD><TD>organelle disassembly</TD><TD>biological process</TD><TD>GO:1903008</TD><TD>199</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.622e-02</TD><TD>-3.32</TD><TD>LINDGREN_BLADDER_CANCER_CLUSTER_3_DN</TD><TD>MSigDB lists</TD><TD>LINDGREN_BLADDER_CANCER_CLUSTER_3_DN</TD><TD>217</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.638e-02</TD><TD>-3.31</TD><TD>V$CDPCR3HD_01</TD><TD>MSigDB lists</TD><TD>V$CDPCR3HD_01</TD><TD>218</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.638e-02</TD><TD>-3.31</TD><TD>V$HP1SITEFACTOR_Q6</TD><TD>MSigDB lists</TD><TD>V$HP1SITEFACTOR_Q6</TD><TD>218</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.668e-02</TD><TD>-3.31</TD><TD>bone-osteosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>bone-osteosarcoma</TD><TD>220</TD><TD>1</TD><TD>17775</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.671e-02</TD><TD>-3.30</TD><TD>PHONG_TNF_RESPONSE_VIA_P38_COMPLETE</TD><TD>MSigDB lists</TD><TD>PHONG_TNF_RESPONSE_VIA_P38_COMPLETE</TD><TD>220</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.677e-02</TD><TD>-3.30</TD><TD>cellular component organization or biogenesis</TD><TD>biological process</TD><TD>GO:0071840</TD><TD>5468</TD><TD>3</TD><TD>16441</TD><TD>3</TD>
<TD>SUN3,PLOD2,MECOM</TD></TR>
<TR><TD>3.684e-02</TD><TD>-3.30</TD><TD>osteosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>osteosarcoma</TD><TD>221</TD><TD>1</TD><TD>17775</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.687e-02</TD><TD>-3.30</TD><TD>DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP</TD><TD>MSigDB lists</TD><TD>DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP</TD><TD>221</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.687e-02</TD><TD>-3.30</TD><TD>V$FOXJ2_02</TD><TD>MSigDB lists</TD><TD>V$FOXJ2_02</TD><TD>221</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.687e-02</TD><TD>-3.30</TD><TD>KYNG_DNA_DAMAGE_UP</TD><TD>MSigDB lists</TD><TD>KYNG_DNA_DAMAGE_UP</TD><TD>221</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.704e-02</TD><TD>-3.30</TD><TD>CTGAGCC,MIR-24</TD><TD>MSigDB lists</TD><TD>CTGAGCC,MIR-24</TD><TD>222</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.707e-02</TD><TD>-3.30</TD><TD>TERF1 (telomeric repeat binding factor (NIMA-interacting) 1)</TD><TD>protein interactions</TD><TD>7013</TD><TD>300</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.720e-02</TD><TD>-3.29</TD><TD>V$PTF1BETA_Q6</TD><TD>MSigDB lists</TD><TD>V$PTF1BETA_Q6</TD><TD>223</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.737e-02</TD><TD>-3.29</TD><TD>V$MZF1_02</TD><TD>MSigDB lists</TD><TD>V$MZF1_02</TD><TD>224</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.737e-02</TD><TD>-3.29</TD><TD>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP</TD><TD>MSigDB lists</TD><TD>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP</TD><TD>224</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.753e-02</TD><TD>-3.28</TD><TD>V$FOXO4_01</TD><TD>MSigDB lists</TD><TD>V$FOXO4_01</TD><TD>225</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.765e-02</TD><TD>-3.28</TD><TD>HER-positive_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>HER-positive_carcinoma</TD><TD>2074</TD><TD>2</TD><TD>17775</TD><TD>3</TD>
<TD>PLOD2,MECOM</TD></TR>
<TR><TD>3.765e-02</TD><TD>-3.28</TD><TD>breast-carcinoma-HER-positive_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>breast-carcinoma-HER-positive_carcinoma</TD><TD>2074</TD><TD>2</TD><TD>17775</TD><TD>3</TD>
<TD>PLOD2,MECOM</TD></TR>
<TR><TD>3.786e-02</TD><TD>-3.27</TD><TD>CACTTTG,MIR-520G,MIR-520H</TD><TD>MSigDB lists</TD><TD>CACTTTG,MIR-520G,MIR-520H</TD><TD>227</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.803e-02</TD><TD>-3.27</TD><TD>V$BRN2_01</TD><TD>MSigDB lists</TD><TD>V$BRN2_01</TD><TD>228</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.836e-02</TD><TD>-3.26</TD><TD>V$SP1_01</TD><TD>MSigDB lists</TD><TD>V$SP1_01</TD><TD>230</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.836e-02</TD><TD>-3.26</TD><TD>V$E2F1_Q4</TD><TD>MSigDB lists</TD><TD>V$E2F1_Q4</TD><TD>230</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.852e-02</TD><TD>-3.26</TD><TD>DOANE_RESPONSE_TO_ANDROGEN_DN</TD><TD>MSigDB lists</TD><TD>DOANE_RESPONSE_TO_ANDROGEN_DN</TD><TD>231</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.852e-02</TD><TD>-3.26</TD><TD>WINTER_HYPOXIA_METAGENE</TD><TD>MSigDB lists</TD><TD>WINTER_HYPOXIA_METAGENE</TD><TD>231</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.852e-02</TD><TD>-3.26</TD><TD>V$YY1_02</TD><TD>MSigDB lists</TD><TD>V$YY1_02</TD><TD>231</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.852e-02</TD><TD>-3.26</TD><TD>V$GATA1_04</TD><TD>MSigDB lists</TD><TD>V$GATA1_04</TD><TD>231</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.890e-02</TD><TD>-3.25</TD><TD>regulation of transmembrane receptor protein serine/threonine kinase signaling pathway</TD><TD>biological process</TD><TD>GO:0090092</TD><TD>216</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.902e-02</TD><TD>-3.24</TD><TD>V$SP1_Q2_01</TD><TD>MSigDB lists</TD><TD>V$SP1_Q2_01</TD><TD>234</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.902e-02</TD><TD>-3.24</TD><TD>NABA_ECM_REGULATORS</TD><TD>MSigDB lists</TD><TD>NABA_ECM_REGULATORS</TD><TD>234</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.918e-02</TD><TD>-3.24</TD><TD>V$MTF1_Q4</TD><TD>MSigDB lists</TD><TD>V$MTF1_Q4</TD><TD>235</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.918e-02</TD><TD>-3.24</TD><TD>V$GATA1_03</TD><TD>MSigDB lists</TD><TD>V$GATA1_03</TD><TD>235</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.934e-02</TD><TD>-3.24</TD><TD>V$AP2GAMMA_01</TD><TD>MSigDB lists</TD><TD>V$AP2GAMMA_01</TD><TD>236</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.934e-02</TD><TD>-3.24</TD><TD>V$E2F_03</TD><TD>MSigDB lists</TD><TD>V$E2F_03</TD><TD>236</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.967e-02</TD><TD>-3.23</TD><TD>V$NFAT_Q6</TD><TD>MSigDB lists</TD><TD>V$NFAT_Q6</TD><TD>238</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>VERHAAK_AML_WITH_NPM1_MUTATED_DN</TD><TD>MSigDB lists</TD><TD>VERHAAK_AML_WITH_NPM1_MUTATED_DN</TD><TD>239</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>3.984e-02</TD><TD>-3.22</TD><TD>HSIAO_LIVER_SPECIFIC_GENES</TD><TD>MSigDB lists</TD><TD>HSIAO_LIVER_SPECIFIC_GENES</TD><TD>239</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.000e-02</TD><TD>-3.22</TD><TD>V$FREAC2_01</TD><TD>MSigDB lists</TD><TD>V$FREAC2_01</TD><TD>240</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.049e-02</TD><TD>-3.21</TD><TD>V$RFX1_01</TD><TD>MSigDB lists</TD><TD>V$RFX1_01</TD><TD>243</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.066e-02</TD><TD>-3.20</TD><TD>V$AP2_Q3</TD><TD>MSigDB lists</TD><TD>V$AP2_Q3</TD><TD>244</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.099e-02</TD><TD>-3.19</TD><TD>ONDER_CDH1_TARGETS_2_UP</TD><TD>MSigDB lists</TD><TD>ONDER_CDH1_TARGETS_2_UP</TD><TD>246</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.099e-02</TD><TD>-3.19</TD><TD>V$GATA_C</TD><TD>MSigDB lists</TD><TD>V$GATA_C</TD><TD>246</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.165e-02</TD><TD>-3.18</TD><TD>WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP</TD><TD>MSigDB lists</TD><TD>WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP</TD><TD>250</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.181e-02</TD><TD>-3.17</TD><TD>V$STAT4_01</TD><TD>MSigDB lists</TD><TD>V$STAT4_01</TD><TD>251</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.197e-02</TD><TD>-3.17</TD><TD>V$OCT1_06</TD><TD>MSigDB lists</TD><TD>V$OCT1_06</TD><TD>252</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.247e-02</TD><TD>-3.16</TD><TD>LU_AGING_BRAIN_UP</TD><TD>MSigDB lists</TD><TD>LU_AGING_BRAIN_UP</TD><TD>255</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.263e-02</TD><TD>-3.16</TD><TD>V$NFAT_Q4_01</TD><TD>MSigDB lists</TD><TD>V$NFAT_Q4_01</TD><TD>256</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.263e-02</TD><TD>-3.16</TD><TD>V$HAND1E47_01</TD><TD>MSigDB lists</TD><TD>V$HAND1E47_01</TD><TD>256</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.269e-02</TD><TD>-3.15</TD><TD>SOX2 (SRY box 2)</TD><TD>protein interactions</TD><TD>6657</TD><TD>346</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>V$OLF1_01</TD><TD>MSigDB lists</TD><TD>V$OLF1_01</TD><TD>257</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.296e-02</TD><TD>-3.15</TD><TD>V$CEBP_01</TD><TD>MSigDB lists</TD><TD>V$CEBP_01</TD><TD>258</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.298e-02</TD><TD>-3.15</TD><TD>regulation of cellular response to growth factor stimulus</TD><TD>biological process</TD><TD>GO:0090287</TD><TD>239</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.329e-02</TD><TD>-3.14</TD><TD>ROZANOV_MMP14_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>ROZANOV_MMP14_TARGETS_UP</TD><TD>260</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.342e-02</TD><TD>-3.14</TD><TD>CREBBP (CREB binding protein)</TD><TD>protein interactions</TD><TD>1387</TD><TD>352</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.427e-02</TD><TD>-3.12</TD><TD>KEGG_MAPK_SIGNALING_PATHWAY</TD><TD>MSigDB lists</TD><TD>KEGG_MAPK_SIGNALING_PATHWAY</TD><TD>266</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.427e-02</TD><TD>-3.12</TD><TD>SMAD3 (SMAD family member 3)</TD><TD>protein interactions</TD><TD>4088</TD><TD>359</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.443e-02</TD><TD>-3.11</TD><TD>YKACATTT_UNKNOWN</TD><TD>MSigDB lists</TD><TD>YKACATTT_UNKNOWN</TD><TD>267</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.493e-02</TD><TD>-3.10</TD><TD>V$GATA1_05</TD><TD>MSigDB lists</TD><TD>V$GATA1_05</TD><TD>270</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.542e-02</TD><TD>-3.09</TD><TD>V$TATA_C</TD><TD>MSigDB lists</TD><TD>V$TATA_C</TD><TD>273</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.640e-02</TD><TD>-3.07</TD><TD>GATAAGR_V$GATA_C</TD><TD>MSigDB lists</TD><TD>GATAAGR_V$GATA_C</TD><TD>279</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.673e-02</TD><TD>-3.06</TD><TD>OXIDOREDUCTASE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>OXIDOREDUCTASE_ACTIVITY</TD><TD>281</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.705e-02</TD><TD>-3.06</TD><TD>BROWNE_HCMV_INFECTION_14HR_DN</TD><TD>MSigDB lists</TD><TD>BROWNE_HCMV_INFECTION_14HR_DN</TD><TD>283</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.738e-02</TD><TD>-3.05</TD><TD>ENDOPLASMIC_RETICULUM</TD><TD>MSigDB lists</TD><TD>ENDOPLASMIC_RETICULUM</TD><TD>285</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.771e-02</TD><TD>-3.04</TD><TD>GTGCCAA,MIR-96</TD><TD>MSigDB lists</TD><TD>GTGCCAA,MIR-96</TD><TD>287</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.794e-02</TD><TD>-3.04</TD><TD>response to hypoxia</TD><TD>biological process</TD><TD>GO:0001666</TD><TD>267</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.857e-02</TD><TD>-3.02</TD><TD>single-organism organelle organization</TD><TD>biological process</TD><TD>GO:1902589</TD><TD>2192</TD><TD>2</TD><TD>16441</TD><TD>3</TD>
<TD>SUN3,PLOD2</TD></TR>
<TR><TD>4.864e-02</TD><TD>-3.02</TD><TD>renal system development</TD><TD>biological process</TD><TD>GO:0072001</TD><TD>271</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.869e-02</TD><TD>-3.02</TD><TD>TACTTGA,MIR-26A,MIR-26B</TD><TD>MSigDB lists</TD><TD>TACTTGA,MIR-26A,MIR-26B</TD><TD>293</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.869e-02</TD><TD>-3.02</TD><TD>IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM</TD><TD>MSigDB lists</TD><TD>IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM</TD><TD>293</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>MECOM</TD></TR>
<TR><TD>4.882e-02</TD><TD>-3.02</TD><TD>response to decreased oxygen levels</TD><TD>biological process</TD><TD>GO:0036293</TD><TD>272</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.902e-02</TD><TD>-3.02</TD><TD>SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN</TD><TD>MSigDB lists</TD><TD>SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN</TD><TD>295</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.902e-02</TD><TD>-3.02</TD><TD>carbohydrate binding</TD><TD>molecular function</TD><TD>GO:0030246</TD><TD>274</TD><TD>1</TD><TD>16491</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.952e-02</TD><TD>-3.01</TD><TD>macroautophagy</TD><TD>biological process</TD><TD>GO:0016236</TD><TD>276</TD><TD>1</TD><TD>16441</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>4.983e-02</TD><TD>-3.00</TD><TD>JIANG_HYPOXIA_NORMAL</TD><TD>MSigDB lists</TD><TD>JIANG_HYPOXIA_NORMAL</TD><TD>300</TD><TD>1</TD><TD>17758</TD><TD>3</TD>
<TD>PLOD2</TD></TR>
<TR><TD>5.000e-02</TD><TD>-3.00</TD><TD>UBE2I (ubiquitin conjugating enzyme E2I)</TD><TD>protein interactions</TD><TD>7329</TD><TD>406</TD><TD>1</TD><TD>16036</TD><TD>2</TD>
<TD>MECOM</TD></TR>
</TABLE>
</BODY></HTML>
